NasdaqGM:NNOXHealthcare
Nano-X Imaging (NNOX) Is Down 36.7% After 2025 Losses Deepen And New CFO Joins - Has The Bull Case Changed?
Nano-X Imaging’s April 2026 update showed fourth-quarter 2025 sales rising to US$3.72 million while net loss widened to US$33.37 million, including a US$17.53 million impairment, alongside full-year 2025 losses and the appointment of incoming CFO Guy Nathanzon after Ran Daniel’s planned departure.
At the same time, a new clinical collaboration with Meir Medical Center to further validate the Nanox.ARC system highlights management’s focus on strengthening the technology’s real-world...